GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Csf2 | increases expression | EXP | | 6480464 | CTD | Calcimycin results in increased expression of CSF2 mRNA | PMID:17950587 PMID:9685678 | Csf2 | increases secretion | EXP | | 6480464 | CTD | Calcimycin results in increased secretion of CSF2 protein | PMID:9685678 | Csf2 | multiple interactions | EXP | | 6480464 | CTD | Luteolin inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA] | PMID:17950587 | Csf2 | multiple interactions | ISO | Csf2 (Mus musculus) | 6480464 | CTD | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]; Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | PMID:1376361 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |